GenVec slices loss in 4th quarter

GenVec Inc., of Gaithersburg, a biopharmaceutical company developing novel gene-based drugs and vaccines, reported a loss of $887,000, or 7 cents per diluted share, for the fourth quarter of 2013, versus a loss of $3.2 million, or 24 cents per share, for the prior-year period.

Leave a Reply

Your email address will not be published. Required fields are marked *